Vanda Pharmaceuticals Inc. financial data

Symbol
VNDA on Nasdaq
Location
2200 Pennsylvania Ave Nw, Suite 300 E, Washington, DC
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Oct 30, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 363 % -24.2%
Quick Ratio 1.77 % +8.57%
Debt-to-equity 25.6 % +30.7%
Return On Equity -16.8 % -457%
Return On Assets -13.4 % -431%
Operating Margin -57.1 % -191%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 59.1M shares +1.35%
Common Stock, Shares, Outstanding 59.1M shares +1.35%
Entity Public Float 320M USD -13.3%
Common Stock, Value, Issued 59K USD +1.72%
Weighted Average Number of Shares Outstanding, Basic 59.1M shares +1.42%
Weighted Average Number of Shares Outstanding, Diluted 59.1M shares +1.42%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 212M USD +11.1%
Revenue from Contract with Customer, Excluding Assessed Tax 212M USD +11.1%
Research and Development Expense 100M USD +26.8%
Costs and Expenses 333M USD +45.9%
Operating Income (Loss) -121M USD -223%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -107M USD -492%
Income Tax Expense (Benefit) -22.9M USD -1252%
Net Income (Loss) Attributable to Parent -84.2M USD -414%
Earnings Per Share, Basic -1 USD/shares -393%
Earnings Per Share, Diluted -1 USD/shares -393%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 70M USD -30.3%
Accounts Receivable, after Allowance for Credit Loss, Current 50.5M USD +18.2%
Inventory, Net 2.04M USD +26.5%
Assets, Current 367M USD -15%
Deferred Income Tax Assets, Net 103M USD +29.9%
Property, Plant and Equipment, Net 2.46M USD +12.9%
Operating Lease, Right-of-Use Asset 4.37M USD -27.4%
Assets 601M USD -6.82%
Employee-related Liabilities, Current 8.75M USD +30.9%
Liabilities, Current 118M USD +32.3%
Operating Lease, Liability, Noncurrent 3.42M USD -37.7%
Other Liabilities, Noncurrent 11M USD +18.5%
Liabilities 135M USD +30.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax 540K USD -23.1%
Retained Earnings (Accumulated Deficit) -254M USD -49.7%
Stockholders' Equity Attributable to Parent 466M USD -13.9%
Liabilities and Equity 601M USD -6.82%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -33.1M USD -538%
Net Cash Provided by (Used in) Financing Activities -1.32M USD
Net Cash Provided by (Used in) Investing Activities 43.9M USD
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 59.1M shares +1.35%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9.48M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 70.5M USD -30.2%
Deferred Tax Assets, Valuation Allowance 8.89M USD +3.98%
Deferred Tax Assets, Gross 92.5M USD +7.71%
Operating Lease, Liability 7.4M USD -21.3%
Depreciation 231K USD +12.1%
Payments to Acquire Property, Plant, and Equipment 436K USD +6129%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -84.4M USD -473%
Lessee, Operating Lease, Liability, to be Paid 8.46M USD -24.4%
Property, Plant and Equipment, Gross 13.7M USD +3.64%
Operating Lease, Liability, Current 2.32M USD -5.58%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.41M USD -13.8%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.79M USD +2.42%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Deferred Income Tax Expense (Benefit) -7.8M USD -3070%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.06M USD -40.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.16M USD -10.4%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 20M shares 0%
Unrecognized Tax Benefits 18.8M USD +2.64%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.1M USD -49.1%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 7.01M USD +8.23%
Deferred Tax Assets, Net of Valuation Allowance 81.4M USD +8.59%
Share-based Payment Arrangement, Expense 10.1M USD -21.7%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%